News

TORONTO, ON – November 15, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Telix Pharmaceuticals, an international biopharmaceutical company, as its newest member organization. Telix Pharmaceuticals (“Telix”) is a commercial-stage biotechnology company producing therapeutic and diagnostic radiopharmaceuticals currently involved in over 20 clinical trials globally and creating innovative radiometal technology within … Read more

TORONTO, ON – November 12, 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to announce that SAGE Engineering Services Ltd. has joined its growing network of leading Canadian supply chain companies. SAGE, an engineering firm established in 2000, operates out of Oakville, Ontario, and offers consultation, professional engineering, and compliance and validation services … Read more

Toronto, Ontario – October 23, 2024 – Yesterday, the Government of Ontario released Ontario’s Affordable Energy Future: The Pressing Case for More Power, which details the province’s rising energy demands and the government’s path to proactively managing this demand. The report also announced the upcoming release of Ontario’s first-ever Integrated Energy Plan to align the energy … Read more

TORONTO, ON — Following months of advocacy from the Canadian Nuclear Isotope Council (CNIC) and its industry partners, the Government of Ontario formally recognized the province’s leadership in the global nuclear isotope sector in today’s Phase 2 update to the government’s Life Sciences Strategy. In the CNIC’s 2023 Isotopes for Hope: Update on Recommendations report, … Read more

TORONTO, ON ­­— September 9, 2024 – James Scongack, Chair of the Canadian Nuclear Isotope Council (CNIC), was awarded the King Charles III Coronation Medal last week, in recognition of his significant contributions to Ontario and Canada. In his role as Chief Operating Officer and Executive Vice President at Bruce Power, and as Chair of … Read more

Toronto – August 14, 2024 – With membership across the isotope supply chain, healthcare sector, and academic institutions, the Canadian Nuclear Isotope Council (CNIC) is committed to ensuring that the Canadian medical isotope industry is staffed with sufficient talent with the appropriate training to support its long-term leadership. The CNIC is pleased to announce that … Read more

Toronto – August 7, 2024 – As part of its mission to ensure patients across Canada have access to the highest standard of medical care and nuclear medicine services, the Canadian Nuclear Isotope Council (CNIC) is proud to announce its new collaboration with the More PETs Coalition. The More PETs Coalition is a group of … Read more

Toronto – July 16 2024 – The Canadian Nuclear Isotope Council (CNIC) is pleased to welcome Agescan International Inc. (Agescan), bringing expertise in medical radiation shielding and strengthening the CNIC’s commitment to innovation and safety in the isotope industry. With customers around the world, Canadian-based Agescan is a rapidly-growing source of tungsten alloy and related … Read more

Toronto, June 10, 2024 – Last week, the Canadian Nuclear Isotope Council (CNIC) celebrated the successful conclusion of the 2024 Canadian Radiotheranostics Leaders’ Summit, held on June 6-7 at the MaRS Discovery District in Toronto. The event was delivered in collaboration with the University Health Network (UHN) and Canadian Medical Isotopes Ecosystem (CMIE), with a … Read more

Toronto – May 28 2024 – Over the past six years, the Canadian Nuclear Isotope Council has worked to expand its membership to encompass the entire isotope production pipeline from coast to coast. Today, CNIC is proud to welcome Rayatom Technologies, an important piece of the Canadian radiopharmaceutical value chain. Based in Kanata, Ontario, Rayatom … Read more